Melatonin ameliorates brain injury induced by systemic lipopolysaccharide in neonatal rats

Neuroscience

Volumn 267, Issue , 2014, Pages 147-156

  Wong, C S ^a,b   Jow, G M ^b   Kaizaki, A ^c   Fan, L W ^d   Tien, L T ^b  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c SHOWA UNIVERSITY   (Japan)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Lipopolysaccharide; Melatonin; Microglia; Mitochondria; Nitrosative and oxidative damage

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MELATONIN; 4-HYDROXY-2-NONENAL; ALDEHYDE; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; CYCLOOXYGENASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN INJURY; BRAIN MITOCHONDRION; CELL ACTIVATION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOCOMOTION; MALE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROMUSCULAR FUNCTION; NEUROPROTECTION; NEWBORN; NITROSATIVE STRESS; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; SENSORIMOTOR FUNCTION; ANIMAL; BRAIN INJURIES; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MUSCLE STRENGTH; PREGNANCY; REACTION TIME; REFLEX; TOXICITY;

ALDEHYDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; BRAIN INJURIES; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT COMPLEX I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MELATONIN; MUSCLE STRENGTH; PREGNANCY; RATS; REACTION TIME; REFLEX;

EID: 84897030500     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.02.032     Document Type: Article

References (44)

1. Altman J., Sudarshan K. Postnatal development of locomotion in the laboratory rat. Anim Behav 1975, 23:896-920.
2. Altman J., Sudarshan K., Das G.D., McCormick N., Barnes D. The influence of nutrition on neural and behavioral development. 3. Development of some motor, particularly locomotor patterns during infancy. Dev Psychobiol 1971, 4:97-114.
3. Aversa S., Pellegrino S., Barberi I., Reiter R.J., Gitto E. Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period. J Matern Fetal Neonatal Med 2012, 25:207-221.
4. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001, 21:1302-1312.
5. Bonnefont-Rousselot D., Collin F. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 2010, 278:55-67.
6. Brzozowska I., Ptak-Belowska A., Pawlik M., Pajdo R., Drozdowicz D., Konturek S.J., Pawlik W.W., Brzozowski T. Mucosal strengthening activity of central and peripheral melatonin in the mechanism of gastric defense. J Physiol Pharmacol 2009, 60(Suppl. 7):47-56.
7. Cai Z., Fan L.W., Kaizaki A., Tien L.T., Ma T., Pang Y., Lin S., Lin R.C., Simpson K.L. Neonatal systemic exposure to lipopolysaccharide enhances susceptibility of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life. Dev Neurosci 2013, 35:155-171.
8. Champy P., Hoglinger G.U., Feger J., Gleye C., Hocquemiller R., Laurens A., Guerineau V., Laprevote O., Medja F., Lombes A., Michel P.P., Lannuzel A., Hirsch E.C., Ruberg M. Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe. J Neurochem 2004, 88:63-69.
9. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992, 149:2736-2741.
10. Chen Y.R., Chen C.L., Zhang L., Green-Church K.B., Zweier J.L. Superoxide generation from mitochondrial NADH dehydrogenase induces self-inactivation with specific protein radical formation. J Biol Chem 2005, 280:37339-37348.
11. Chen Y.C., Tain Y.L., Sheen J.M., Huang L.T. Melatonin utility in neonates and children. J Formos Med Assoc 2012, 111:57-66.
12. Colton C.A., Gilbert D.L. Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol 1993, 59:321-326.
13. Crespo E., Macias M., Pozo D., Escames G., Martin M., Vives F., Guerrero J.M., Acuna-Castroviejo D. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999, 13:1537-1546.
14. Deguchi K., Oguchi K., Matsuura N., Armstrong D.D., Takashima S. Periventricular leukomalacia: relation to gestational age and axonal injury. Pediatr Neurol 1999, 20:370-374.
15. Esposito E., Cuzzocrea S. Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 2010, 8:228-242.
16. Fan L.W., Chen R.F., Mitchell H.J., Lin R.C., Simpson K.L., Rhodes P.G., Cai Z. Alpha-phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced brain injury and improves neurological reflexes and early sensorimotor behavioral performance in juvenile rats. J Neurosci Res 2008, 86:3536-3547.
17. Fan L.W., Mitchell H.J., Rhodes P.G., Cai Z. Alpha-phenyl-n-tert-butyl-nitrone attenuates lipopolysaccharide-induced neuronal injury in the neonatal rat brain. Neuroscience 2008, 151:737-744.
18. Fan L.W., Mitchell H.J., Tien L.T., Zheng B., Pang Y., Rhodes P.G., Cai Z. Alpha-phenyl-n-tert-butyl-nitrone reduces lipopolysaccharide-induced white matter injury in the neonatal rat brain. Dev Neurobiol 2008, 68:365-378.
19. Fan L.W., Kaizaki A., Tien L.T., Pang Y., Tanaka S., Numazawa S., Bhatt A.J., Cai Z. Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. Neuroscience 2013, 240:27-38.
20. Gitto E., Pellegrino S., Gitto P., Barberi I., Reiter R.J. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009, 46:128-139.
21. Gitto E., Aversa S., Reiter R.J., Barberi I., Pellegrino S. Update on the use of melatonin in pediatrics. J Pineal Res 2011, 50:21-28.
22. Harden N., Lee J., Loh H.Y., Ong Y.M., Tan I., Leung T., Manser E., Lim L. A Drosophila homolog of the Rac- and Cdc42-activated serine/threonine kinase PAK is a potential focal adhesion and focal complex protein that colocalizes with dynamic actin structures. Mol Cell Biol 1996, 16:1896-1908.
23. Haynes R.L., Folkerth R.D., Keefe R.J., Sung I., Swzeda L.I., Rosenberg P.A., Volpe J.J., Kinney H.C. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003, 62:441-450.
24. Hermans R.H., Hunter D.E., McGivern R.F., Cain C.D., Longo L.D. Behavioral sequelae in young rats of acute intermittent antenatal hypoxia. Neurotoxicol Teratol 1992, 14:119-129.
25. Hoglinger G.U., Lannuzel A., Khondiker M.E., Michel P.P., Duyckaerts C., Feger J., Champy P., Prigent A., Medja F., Lombes A., Oertel W.H., Ruberg M., Hirsch E.C. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem 2005, 95:930-939.
26. Kaizaki A., Tien L.T., Pang Y., Cai Z., Tanaka S., Numazawa S., Bhatt A.J., Fan L.W. Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide. J Neuroinflamm 2013, 10:45.
27. Leon J., Acuna-Castroviejo D., Sainz R.M., Mayo J.C., Tan D.X., Reiter R.J. Melatonin and mitochondrial function. Life Sci 2004, 75:765-790.
28. Lin G.J., Huang S.H., Chen S.J., Wang C.H., Chang D.M., Sytwu H.K. Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases. Int J Mol Sci 2013, 14:11742-11766.
29. Lopez A., Garcia J.A., Escames G., Venegas C., Ortiz F., Lopez L.C., Acuna-Castroviejo D. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009, 46:188-198.
30. Mauriz J.L., Collado P.S., Veneroso C., Reiter R.J., Gonzalez-Gallego J. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013, 54:1-14.
31. Meng S.Z., Arai Y., Deguchi K., Takashima S. Early detection of axonal and neuronal lesions in prenatal-onset periventricular leukomalacia. Brain Dev 1997, 19:480-484.
32. Olivier P., Fontaine R.H., Loron G., Van Steenwinckel J., Biran V., Massonneau V., Kaindl A., Dalous J., Charriaut-Marlangue C., Aigrot M.S., Pansiot J., Verney C., Gressens P., Baud O. Melatonin promotes oligodendroglial maturation of injured white matter in neonatal rats. PLoS One 2009, 4:e7128.
33. Ozdemir D., Uysal N., Tugyan K., Gonenc S., Acikgoz O., Aksu I., Ozkan H. The effect of melatonin on endotoxemia-induced intestinal apoptosis and oxidative stress in infant rats. Intensive Care Med 2007, 33:511-516.
34. Pang Y., Cai Z., Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res 2003, 140:205-214.
35. Pleasure D., Soulika A., Singh S.K., Gallo V., Bannerman P. Inflammation in white matter: clinical and pathophysiological aspects. Ment Retard Dev Disabil Res Rev 2006, 12:141-146.
36. Radogna F., Diederich M., Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010, 80:1844-1852.
37. Raza H., John A. 4-Hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione S-transferase A4-4 and cytochrome P450 2E1 in PC12 cells. Toxicol Appl Pharmacol 2006, 216:309-318.
38. Rezaie P., Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002, 22:106-132.
39. Sanchez-Barcelo E.J., Mediavilla M.D., Reiter R.J. Clinical uses of melatonin in pediatrics. Int J Pediatr 2011, 2011:892624.
40. Shinozuka K., Staples M., Borlongan C.V. Melatonin-based therapeutics for neuroprotection in stroke. Int J Mol Sci 2013, 14:8924-8947.
41. Srinivasan V., Pandi-Perumal S.R., Spence D.W., Kato H., Cardinali D.P. Melatonin in septic shock: some recent concepts. J Crit Care 2010, 25(656):e651-e656.
42. Thorburne S.K., Juurlink B.H. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 1996, 67:1014-1022.
43. Villapol S., Fau S., Renolleau S., Biran V., Charriaut-Marlangue C., Baud O. Melatonin promotes myelination by decreasing white matter inflammation after neonatal stroke. Pediatr Res 2011, 69:51-55.
44. Volpe J.J. Cerebral white matter injury of the premature infant-more common than you think. Pediatrics 2003, 112:176-180.